Diana Marr Bio

Diana has 22 years of experience in private equity and corporate finance. She is responsible for managing the investment process, including the sourcing, analysis, monitoring and exiting of investments. Diana currently serves as member or observer on the boards/LPAC of Amethyst Radiotherapy, Optimapharm and MyFamily. Before joining Keyhaven, Diana was a Managing Director in the M&A team at BDO Corporate Finance leading M&A transactions in technology and media, business services and consumer sectors. Prior to this, she was a Senior Corporate Finance Advisor at Clarges Capital Limited and Bridge Europe Consulting in London and a Senior Investment Manager at Gemisa Investments in the CEE. Diana started her career at AIG - New Europe Fund, American International Group Capital Management’s private equity fund based in the CEE. Diana has BA degrees in Business Administration and Political Science/International Relations from the American University in Bulgaria and an MSc in Finance from Bayes Business School in London. She is fluent in English, Romanian, French and she also speaks conversational Italian.